Shire plc (SHPG)


NasdaqGS - NasdaqGS Real Time Price. Currency in USD
190.40-0.28 (-0.15%)
At close: 4:00 PM EDT
People also watch:
JAZZALXNMDVNMNKBMRN
Interactive chart
  • 1d
  • 5d
  • 1m
  • 6m
  • YTD
  • 1y
  • 2y
  • 5y
  • 10y
  • Max
1d
Open189.83
Prev Close190.68
Bid190.90 x 500
Ask191.08 x 400
Day's Range189.56 - 191.10
52wk Range147.60 - 231.32
1y Target EstN/A
Market Cap56.71B
P/E Ratio (ttm)39.57
Beta1.54
Volume321,748
Avg Vol (3m)2,057,085
Dividend & Yield0.80 (0.42%)
Earnings DateN/A
Trade prices are not sourced from all markets
  • PR Newswire17 hours ago

    Shire's First Prescription Eye Drop, Xiidra™ (lifitegrast ophthalmic solution) 5% Is Now Available in the U.S.

    LEXINGTON, Mass., Aug. 29, 2016 /PRNewswire/ -- Shire plc (LSE: SHP, NASDAQ: SHPG) today announced that Xiidra™ (lifitegrast ophthalmic solution) 5%, a twice-daily prescription eye drop indicated for the treatment of both the signs and symptoms of dry eye disease, is now available by prescription in the United States. An estimated 16 million adults in the U.S. are diagnosed with dry eye, a disease associated with inflammation that may eventually lead to damage to the surface of the eye. An eye care professional can diagnose dry eye disease based on signs and symptoms and determine management options, which could include the use of a prescription treatment.

  • PR Newswire19 hours ago

    Shire's First Prescription Eye Drop, Xiidra™ (lifitegrast ophthalmic solution) 5% is Now Available in the U.S.

    Shire plc (LSE: SHP, NASDAQ: SHPG) today announced that Xiidra™ (lifitegrast ophthalmic solution) 5%, a twice-daily prescription eye drop indicated for the treatment of both the signs and symptoms of dry eye disease, is now available by prescription in the United States. An estimated 16 million adults in the U.S. are diagnosed with dry eye, a disease associated with inflammation that may eventually lead to damage to the surface of the eye. An eye care professional can diagnose dry eye disease based on signs and symptoms and determine management options, which could include the use of a prescription treatment.

  • Billionaire John Paulson’s Favorite Healthcare Stocks Include The Latest Industry Punching Bag, Mylan
    Insider Monkey3 days ago

    Billionaire John Paulson’s Favorite Healthcare Stocks Include The Latest Industry Punching Bag, Mylan

    John Paulson is an American hedge fund manager and billionaire who founded his investment firm Paulson & Co in 1994 with only $2 million and one employee. By 2003, the fund’s assets had grown to $300 million. In 2006, Mr. Paulson started the famous ‘Credit Opportunities Fund’, which mainly bet against subprime mortgages. John Paulson […]